Latest Retail Entitlement Offers News

Babylon Pump & Power has successfully closed its institutional entitlement offer, raising over $1 million through the issuance of 271 million new shares. A retail entitlement offer is set to follow, providing existing shareholders another chance to participate.

Ridley Corporation has successfully raised approximately $99 million through an institutional placement and entitlement offer to partly fund its $300 million acquisition of Dyno Nobel’s fertiliser distribution business. The capital raising received strong support from institutional investors, setting the stage for a retail entitlement offer later this month.

Ridley Corporation announces a $300 million acquisition of Incitec Pivot Fertilisers Distribution, aiming to boost earnings and diversify its agricultural services portfolio. The deal includes a $125 million equity raise and strategic supply agreements.

Mighty Kingdom Limited has completed its entitlement offer, raising approximately A$475,000 through the issuance of 95 million new shares, yet a significant shortfall remains to be placed with investors.

Mighty Kingdom Limited reports a positive operating cash inflow and significant cost reductions in Q3 FY25, alongside leadership changes and a $3.35 million capital raise underway to fuel growth.

betr Entertainment has successfully raised $130 million through a fully underwritten equity offer priced at a 13.7% premium, underpinning its strategic acquisition of PointsBet and positioning for growth in the Australian wagering market.

Clara Resources is gearing up for a pivotal drilling campaign at its Ashford Coking Coal Project while successfully raising $1.245 million through an entitlement offer and placement. The company also navigates significant board changes and continues exploration at its Kildanga Nickel/Cobalt project.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

PYC Therapeutics is set to raise up to $146 million through a pro-rata entitlement offer, aiming to accelerate its RNA-based drug candidates targeting major unmet medical needs. Major shareholder support and underwriting commitments underpin the capital raise.

WA Kaolin has launched its retail entitlement offer following the distribution of its prospectus, inviting eligible shareholders to participate in a key capital raising initiative.

Micro-X Limited has initiated a $2.7 million retail entitlement offer as part of a broader $6 million capital raising, supporting its strategic pivot towards medical imaging technologies and strengthening its balance sheet.

Micro-X Ltd has launched the retail component of its $6 million capital raising, offering eligible shareholders the chance to buy new shares at 7 cents each, aiming to raise $2.7 million by late February 2025.